Cargando…
An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo
The use of antibody-based therapy to treat a variety of diseases and conditions is well documented. The use of antibodies as an antidote to treat tetanus infections was one of the first examples of immunotherapy and remains the standard of care for cases involving potential infections. Plasma-derive...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285915/ https://www.ncbi.nlm.nih.gov/pubmed/32550563 http://dx.doi.org/10.1016/j.toxcx.2019.100006 |